Cargando…
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
BACKGROUND: Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well...
Autores principales: | Hadji, Peyman, Aapro, Matti S., Body, Jean-Jacques, Gnant, Michael, Brandi, Maria Luisa, Reginster, Jean Yves, Zillikens, M. Carola, Glüer, Claus-C., de Villiers, Tobie, Baber, Rod, Roodman, G. David, Cooper, Cyrus, Langdahl, Bente, Palacios, Santiago, Kanis, John, Al-Daghri, Nasser, Nogues, Xavier, Eriksen, Erik Fink, Kurth, Andreas, Rizzoli, Rene, Coleman, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384888/ https://www.ncbi.nlm.nih.gov/pubmed/28413771 http://dx.doi.org/10.1016/j.jbo.2017.03.001 |
Ejemplares similares
-
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – the “Wco-iof-esceo Congress”: The 18th edition of the WCO-IOF-ESCEO Congress – Krakow 2018
por: Maślińska, Maria
Publicado: (2018) -
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N. R., et al.
Publicado: (2021) -
Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N.R., et al.
Publicado: (2021) -
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021)
Publicado: (2022) -
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
Publicado: (2022)